Compounds > ribavirin
Page last updated: 2024-08-16

ribavirin and Armstrong Syndrome

ribavirin has been researched along with Armstrong Syndrome in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Furuta, Y; Gowen, BB; Hickerson, BT; Jung, KH; Komeno, T; Westover, JB1
Aebischer, O; Kunz, S; Lazor-Blanchet, C; Meylan, P1
de la Torre, JC1
Berger, DP; Homann, D; Oldstone, MB; Sette, A; Tishon, T; von Herrath, MG1
Hengartner, H; Kalinke, U; Klenerman, P; Seiler, P; Senn, BM; Zinkernagel, RM1
Barrera Oro, JG; Jahrling, PB; Kenyon, RH; Liu, CT; McKee, KT; Peters, CJ1

Other Studies

6 other study(ies) available for ribavirin and Armstrong Syndrome

ArticleYear
Effective Treatment of Experimental Lymphocytic Choriomeningitis Virus Infection: Consideration of Favipiravir for Use With Infected Organ Transplant Recipients.
    The Journal of infectious diseases, 2018, 07-13, Volume: 218, Issue:4

    Topics: Amides; Animals; Antiviral Agents; Disease Models, Animal; Female; Immunocompromised Host; Lymphocytic Choriomeningitis; Lymphocytic choriomeningitis virus; Male; Mice, Inbred NZB; Pyrazines; Ribavirin; Survival Analysis; Transplant Recipients; Treatment Outcome; Viral Load

2018
Lymphocytic choriomeningitis virus infection induced by percutaneous exposure.
    Occupational medicine (Oxford, England), 2016, Volume: 66, Issue:2

    Topics: Accidents, Occupational; Adult; Antiviral Agents; Humans; Lymphocytic Choriomeningitis; Lymphocytic choriomeningitis virus; Male; Needlestick Injuries; Occupational Exposure; Post-Exposure Prophylaxis; Practice Guidelines as Topic; Ribavirin; Treatment Outcome

2016
Molecular and cell biology of the prototypic arenavirus LCMV: implications for understanding and combating hemorrhagic fever arenaviruses.
    Annals of the New York Academy of Sciences, 2009, Volume: 1171 Suppl 1

    Topics: Animals; Antiviral Agents; Arenaviridae; Arenaviridae Infections; Bioterrorism; Disease Models, Animal; Genome, Viral; Humans; Lassa Fever; Lassa virus; Lymphocytic Choriomeningitis; Lymphocytic choriomeningitis virus; Ribavirin; RNA, Viral; United States; Viral Vaccines

2009
Vaccination to treat persistent viral infection.
    Virology, 2000, Mar-15, Volume: 268, Issue:2

    Topics: Adoptive Transfer; Animals; Antiviral Agents; Epitopes, T-Lymphocyte; Lipoproteins; Lymphocytic Choriomeningitis; Lymphocytic choriomeningitis virus; Mice; Mice, Inbred BALB C; Nucleoproteins; Peptides; Ribavirin; Vaccines, Inactivated; Viral Proteins; Viral Vaccines

2000
Additive effect of neutralizing antibody and antiviral drug treatment in preventing virus escape and persistence.
    Journal of virology, 2000, Volume: 74, Issue:13

    Topics: Animals; Antibodies, Viral; Antiviral Agents; Base Sequence; Cell Line; Cricetinae; DNA, Viral; Female; Genetic Variation; Immunoglobulin mu-Chains; Lymphocytic Choriomeningitis; Lymphocytic choriomeningitis virus; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Molecular Sequence Data; Neutralization Tests; Ribavirin; Virus Latency

2000
Experimental studies of arenaviral hemorrhagic fevers.
    Current topics in microbiology and immunology, 1987, Volume: 134

    Topics: Animals; Arenaviridae; Arenaviridae Infections; Cricetinae; Disease Models, Animal; Guinea Pigs; Haplorhini; Hemorrhagic Fever, American; Hemorrhagic Fevers, Viral; Immune Tolerance; Lassa Fever; Lymphocytic Choriomeningitis; Mice; Ribavirin

1987